Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells

BACKGROUND: Norcantharidin (NCTD) is a Chinese FDA approved, chemically synthesized drug for cancer treatment. The effect of NCTD on signaling proteins of EGFR and c-Met was systematically elucidated in current study. METHODS: Two human colon cancer cell lines, HCT116 and HT29, were used as model sy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Qiu, Peiju, Wang, Siwen, Liu, Ming, Ma, He, Zeng, Xuan, Zhang, Meng, Xu, Lingling, Cui, Yidi, Xu, Huixin, Tang, Yang, He, Yanli, Zhang, Lijuan
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5237309/
https://ncbi.nlm.nih.gov/pubmed/28086832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-3039-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados